plasma cells, 3% lymphocytes and 3% megakaryocytes. Significant dysmyelopoiesis was noted in the form of cytoplasmic hypogranularity and nuclear hyposegmentation, pseudo-Pelger Huet cells and pseudo-Chediak Higashi inclusions. Erythroid and megakaryocytic hyperplasia and dysplasia were also seen; including hypolobated and monolobated megakaryocytes, and erythroblasts with nuclear budding and multinucleation. Iron stain (Perls' Prussian blue) showed increased iron stores with occasional (\5%) ringed sideroblasts. Based on the morphology, a diagnosis of myelodysplastic syndrome with excess blasts (RAEB) was rendered [1] . Karyotyping on the bone marrow aspirate revealed a hypotriploid clone [59, XY, add (1) (p33)].
Myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases characterized by ineffective erythropoiesis and dysplasia of one or more major myeloid cell lines, often clinically suspected in cases of refractory anemia or pancytopenia, especially in the elderly [1] . Clinical and diagnostic overlaps may exist in MDS and megaloblastic anemia or multiple nutritional deficiencies. A combination of bone marrow examination with cytogenetics remains the gold standard for MDS diagnosis. Diagnostic challenges in MDS may arise due to the diversity in morphological presentations (subtle changes being particularly troublesome), subjectivity and inter-observer variability in recognizing dysplasia, and the fact that karyotyping is normal in *50% cases [2] .
The XN 3000 automated five-part analyzer applies the principle of flow cytometry using a semiconductor laser for leukocyte analysis. Special surfactants and fluorescent dye in the reagents distinguish the cells using side scatter light (NE-SSC/NEUT-X) and side fluorescence (NE-SFL/ NEUT-Y) [3] . These constitute the cell population data, analysis of which helps to differentiate and count various & Preethi S. Chari preethichari@gmail.com Sujay Prasad sujayprasad@mac.com cells and flag abnormal cells. In MDS, the dysplastic neutrophils show reduced side scatter and side fluorescence due to hypogranularity and dysfunction respectively, findings validated by prior large studies [4] .
In conclusion, our experience with this case suggests that leucocyte population data analysis could be a useful and objective screening tool for MDS. However, studies on temporal stability of these parameters, interanalyzer variations, non-neoplastic mimics, and establishment of agespecific reference ranges are likely to be necessary for their clinical implementation on a large scale.
